-
GENFIT NASDAQ:GNFT
Location: Parc Eurasante 885 avenue Eugene Avinee, Hauts De France, 59120, France | Website: https://www.genfit.fr/ | Industry: Biological Product (except Diagnostic) Manufacturing | Sector: Manufacturing
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
282M
Cash
61.65M
Avg Qtr Burn
-10.39M
Short % of Float
0.16%
Insider Ownership
0.00%
Institutional Own.
0.15%
Qtr Updated
06/30/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Iqirvo® (elafibranor) Details Primary biliary cholangitis, Liver disease | Approved Quarterly sales | |
VS-01 Details Acute-on-Chronic liver failure, Liver disease | Phase 2 Data readout | |
Nitazoxanide (NTZ) Details Non-alcoholic steatohepatitis , Acute-on-Chronic liver failure, Liver disease | Phase 2 Initiation | |
GNS561 Details Liver disease, Cholangiocarcinoma | Phase 1b Data readout | |
Iqirvo® (elafibranor) Details Non-alcoholic steatohepatitis | Failed Discontinued |